9amHealth, Instacart tackle obesity with healthy food and GLP-1s: We think that employer and health plan customers will be pleased with the program’s less costly approach than prescription weight loss drugs alone.

Global consumers feel pressured by society to improve their well-being: Marketers have a unique opportunity to re-write the narrative of the well-being space with a lighter spin.

Most patients are anxious before going to the doctor: But they settle in once they’re in the appointment. We explore how healthcare marketers and providers could use these patient sentiments to their advantage.

Advocate Health cancels liens, forgives medical debt of thousands: The health system’s abrupt decision to forgive patients’ debt is a play to save face after the results of an eye-opening investigation were published.

FDA approves AstraZeneca’s flu vaccine for at-home administration: But we’re not certain FluMist’s convenient nasal spray format gives it enough of an edge over traditional vaccines to drive adoption among vaccine hesitant Americans.

The US healthcare system spends high, but ranks low on overall performance: We unpack the reasons why the US is performing worse than all other high-income countries when it comes to delivering healthcare, and explore how the upcoming presidential election could signal changes.

Hackensack Meridian Health, K Health roll out 24/7 primary care service: Incumbents like Hackensack Meridian are responding to patient expectations for convenient access to healthcare.

Healthcare providers, payers increase IT investments: In light of the devastating fallout of the cyberattack on Change Healthcare, providers and payers alike are hedging against future cybersecurity threats.

23andMe’s board resigns: After years of ill-fated endeavors, the en masse resignation marks the latest blow to 23andMe, which has been hemorrhaging cash and yet to turn a profit.

Express Scripts sues the FTC: The pharmacy benefit manager is demanding the retraction of an agency report critical of pharma’s middlemen. Even if that happens, the damage to PBMs’ reputation is done.

Senators target misleading drug ads on social media with new legislation: We examine the ramifications for marketers and ad agencies who are part of the health influencer economy.

Amazon adds Talkspace to digital health benefits program: The partnership dovetails with Talkspace’s push to reach more patients by partnering with health insurers and employers.

Elevance, doctors quarrel over volume of Ozempic prescriptions: The insurer doesn’t want to cover Ozempic to treat obesity. But are healthcare providers the ones to blame?

Kourtney Kardashian’s Lemme rolls out “GLP-1” weight loss supplement: The move is ingenious from a marketing perspective. But the brand could find itself in drugmakers’ crosshairs with already confusing marketing about the supplement’s key ingredient.

Health insurers’ use of AI tools linked to soaring claim denials: The claim denials process has become maddening for patients and providers alike.

Most healthcare AI startups want to sell their solutions to health systems: But these tech companies struggle to demonstrate their value prop to potential healthcare provider buyers.

More women than men skip out on medical care: Marketers should make more meaningful connections with female consumers, many of whom are the key healthcare decision-makers in their households.

FDA warns AbbVie for misleading TV ad ft. Serena Williams: Pharma marketers—particularly those who work with celebrities—ought to pay close attention to the regulator’s assertions.

Each patient generation takes a unique path on their health journey: We unpack the channels where patients begin their health journeys and explore how marketers can tailor their engagement strategies to best reach each generation.

Noom gets into compounded GLP-1s with a taper-off guarantee: It’s building a weight loss program around the idea that patients will eventually want to stop taking the medications. We explore the pros and cons.